William Davenport, MD
Orthopaedic Surgery · Orlando, FLNPI 1770545055
Payments from drug & device makers
Across 86 payments — averaging $90.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Arthrex$2K
- Reel Surgical, Inc.$2K
- Johnson & Johnson Surgical Vision, Inc.$116
- Sun Pharmaceutical Industries Inc.$92
- Johnson & Johnson$86
- plus $290 from 12 others
What the payments were for
- Travel & lodging$2,88737%
- Food & beverage$2,27529%
- Education$1,90725%
- Gifts$6929%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 22 | $2,820 |
| Arthrex | 33 | $2,283 |
| Reel Surgical, Inc. | 3 | $2,074 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $116 |
| Sun Pharmaceutical Industries Inc. | 4 | $92 |
| Johnson & Johnson(2 entities) | 4 | $86 |
| Ferring Pharmaceuticals Inc. | 2 | $44 |
| Endo USA, Inc. | 2 | $41 |
| Smith+Nephew | 1 | $40 |
| ERMI LLC | 2 | $35 |
| Cumberland Pharmaceuticals, Inc. | 2 | $23 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
| Innovation Technologies Inc | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Zimmer Biomet | 1 | $14 |
| Vericel Corporation | 1 | $14 |
| Convatec Inc. | 1 | $13 |
| Heron Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,701
- SIMPLICITI$692
How this compares
$7,761 in reported general payments places this provider in the 50th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 75 | $974 |
| Meloxicam | 266 | $663 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $349 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $246 |
| Ibuprofen | 27 | $147 |
| Prednisone | 11 | $129 |
| Naproxen | 15 | $105 |
| Cephalexin | 14 | $47 |
| Tramadol Hcl | 14 | $29 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Orlando
- George HaidukewychOrlando$10M
- Sean McFaddenOrlando$4.1M
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$35M
- Mark FrankleTemple Terrace$31.4M
- David WatsonTemple Terrace$21M
- Roy SandersTemple Terrace$19.6M
- Martin RocheFt. Lauderdale$7.3M
- Robert SantrockFernandina Beach$7.3M
- Steven LyonsTampa$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.